Investigational chimeric antigen receptor natural killer cell therapy NKX101 associated with promising early response in patients with relapsed/refractory acute myeloid leukemia
Cleveland Clinic oncologists’ selected abstracts
Immunological pressure driving genetic mutations
Findings of a new study emphasize the importance of psychosocial support for patients and families
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy